Log In
BCIQ
Print this Print this
 

miRCURY LNA Universal RT miRNA PCR platform

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionGenome-wide locked nucleic acid (LNA)-based platform for identifying miRNA biomarkers associated with cancer in blood samples
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsEarly detection of colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$102.3M

$102.3M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/28/2016

$102.3M

$102.3M

0

07/26/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today